DNA damage and growth inhibition in cultured human cells by bleomycin congeners.
Bleomycin is hypothesized to cause cell growth inhibition and cell death via DNA cleavage. We have attempted to determine if net DNA cleavage is directly related to growth inhibition by measuring whether both parameters vary in parallel. Of primary importance to these studies was use of several bleomycin congeners. We have shown that these congeners vary in their abilities both to inhibit cell growth and to cause DNA damage. Bleomycin B2, tallysomycin, and phleomycin were the most potent growth inhibitors, and bleomycin B2 caused the most DNA damage. N-Acetylbleomycin A2 was inactive in both assays. The net amount of DNA damage measured at two levels of growth inhibition was compared for each congener and was found to vary widely among the congeners. Similarly, the degree of growth inhibition at a given level of submaximal DNA damage was found to vary widely when individual congeners were compared to each other. Hence, growth inhibition and net DNA damage due to bleomycin are not directly correlated with each other when individual congeners are compared to each other.
D E
DE
Berry
L H
LH
Chang
S M
SM
Hecht
D001761:Bleomycin / Q000494:pharmacology*; D002277:Carcinoma; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D004260:DNA Repair / Q000187:drug effects*; D004273:DNA, Neoplasm / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D009062:Mouth Neoplasms; D013329:Structure-Activity Relationship
D004273:DNA, Neoplasm; D001761:Bleomycin